China’s new anti-bribery agency announces pharma probe

Published date25 May 2018
Law FirmAllen & Overy LLP
AuthorFrançois Renard,Jason Gray,David Shen,Caroline Marshall,Evelyn Mo
Subject MatterMedical Devices,Anti-Bribery,China,Unfair Competition,Pharmaceutical Industry

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT